Aphria (NYSE:APHA) is down 11% year-to-date but that situation is likely to reverse. That is because Aphria is one of the only cannabis stocks that is profitable. Its profitability will increase next ...

For a well-known asset listed on the New York Stock Exchange, Aphria stock is surprisingly affordable and could easily fit into practically anyone’s budget. Don’t be tricked into thinking that cheap ...

On the one hand, it’s tempting to dismiss Aphria’s results as not being a big deal. Aphria is a scandal-plagued company whose former management quit. Short sellers attacked the company for allegedly ...

The legal cannabis industry is still in the early innings of growth and as such, it is fragmented, fraught with risk and also chock full of potentially compelling growth stories. As legal marijuana is ...

If you're a value investor, neither one of these marijuana stocks looks attractive. Aphria stock trades at 136 times sales, while MedReleaf's price-to-sales ratio is nearly 56. But no marijuana stock ...

Shares of Electronic Arts dropped 13% after the video game manufacturer reported lackluster results for its fiscal third quarter. EA said that net revenue rose just 11% during the period, and although ...

Shares of Tilray soared nearly 17% after the cannabis company announced a new collaboration with pharmaceutical giant Novartis (NYSE: NVS). The pharma company's Sandoz generic drug business entered ...